A study by CUNY SPH researchers, in close partnership with colleagues from Weill Cornell Medicine and NYU School of Medicine, suggests that treating people who inject drugs for hepatitis C infection using the accessible care ...
Mar 24, 2022
0
0
Researchers have discovered in mice an additional use of globins as an intravenous drug that can delay liver fibrosis progression. Last year, the application of recombinant human cytoglobin (CYGB) as a protein therapeutic ...
Mar 23, 2022
0
17
Invading armies need a steady supply of fuel and armaments. That's just as true when the invaders are cells, such as when tumor cells break away from their neighbors and spread to other parts of the body in a process called ...
Mar 22, 2022
0
83
Cognitive impairment among older hospitalized Australians could be the result of low vitamin C levels, a Flinders University-led study has found, paving the way for a potential treatment.
Mar 21, 2022
0
4
Pathogens don't always work against drug treatments. Sometimes, they can strengthen them, according to a new University of Maine study.
Mar 15, 2022
0
82
Experts at the Linus Pauling Institute sponsored an extremely interesting presentation of vitamin C this week. You may remember Dr. Pauling, a brilliant and sometimes controversial chemist who published numerous books and ...
Mar 11, 2022
0
80
The American College of Rheumatology (ACR), in partnership with the Vasculitis Foundation (VF), released a new guideline for the management of Kawasaki disease that addresses diagnostic issues relating to Kawasaki disease, ...
Mar 8, 2022
0
8
A new study by physicians at Columbia University Vagelos College of Physicians and Surgeons has identified unique features of MIS-C, a rare but potentially deadly complication of COVID in children, that suggest how the syndrome ...
Mar 4, 2022
0
20
More than 70 million people worldwide are infected with hepatitis C. The disease is treatable, but it is often not recognized. In 80% of cases, it takes chronic courses and can lead to liver damage and even liver cancer. ...
Mar 2, 2022
0
12
Several FDA-approved drugs—including for type 2 diabetes, hepatitis C and HIV—significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists ...
Feb 25, 2022
2
292
